Most colorectal patients report financial burden due to treatment
the ONA take:
The burden of cancer and its treatment goes beyond the obvious medical and physical challenges. Many patients experience significant financial hardship as well. Researchers at the University of Michigan Comprehensive Cancer Center conducted a study on the financial burden of colorectal cancer.
They surveyed 956 patients identified through the Surveillance, Epidemiology and End Results cancer registries for the Metro Detroit area and the stage of Georgia. The patients were asked to complete a seven-question survey that asked whether they employed such financial strategies as using savings, borrowing money, skipping bill payments, or cutting back on expenses (eg, food, clothing, or recreational activities).
Overall, 62% of respondents indicated areas of burdens, based on the seven questions. More specifically, the study demonstrated that younger patients who worked in low-paying jobs and those who received chemotherapy were most likely to endure financial burdens.
Based on their findings, the researchers advocate changes to job-related policies that would allow patients to focus on adhering to their treatments, and provide support for both copays and nonmedical expenses related to getting to treatment appointments. Most importantly, however, the researchers encourage clinicians to openly discuss financial situations and support options with patients.
Researchers conducted a study on the financial burden of colorectal cancer.
Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center. The burden was greatest among patients who received chemotherapy and among younger patients who worked in low-paying jobs.
The study surveyed 956 patients who had been treated for stage 3 colorectal cancer. Among this group, chemotherapy is known to increase survival by up to 20 percent and is routinely recommended following surgery.
- Immunotherapy May Benefit Some Patients with Papillary Thyroid Carcinoma
- Screening Recommendations for Children with Common Cancer Predisposition Syndromes
- Significance of Prostate Cancer Treatment-Related Factors Differ in Black, White Men
- Superior Tolerability, Efficacy With Alectinib in Treatment-Naïve ALK-poistive NSCLC
- New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer
- Survivorship Care Plans: Providing A Blueprint for Health Care After Cancer
- Multifaceted Role of the Nurse Navigator Includes Palliative, Supportive Care
- Cancer Recurrence Fear Reduced by Novel Psychological Intervention
- Patient Navigators Found to Boost Lung Cancer Screening Rates
- Lack of Transfusion Services a Barrier to Hospice Care for Patients With Blood Cancers
- Aspirin Use May Lower Breast Cancer Risk in Women with Diabetes
- Ethnic Differences, Cultural Barriers Negatively Impact Mammography Follow-up Among Asian Ethnic Groups
- Study Questions Safety of E-cigarettes vs Regular Tobacco Cigarettes
- Changes in Pulmonary Function Tests in Breast Carcinoma Patients Treated With Locoregional Post-mastectomy Radiotherapy: Results of a Pilot Study
- Increases in Liver Cancer Incidence Influenced by Higher Rates of Comorbidities
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|